Dr. Thomas J Harrington MD

Recommended Articles

• Touchdown For Lymphoma: Two Teams Put Rivalry Aside For a Cause

  Everyone knows that some rivalries can get pretty heated - especially when sports are involved. However, two football teams recognize that there is something more important - supporting a girl with Hodgkin's lymphoma. Although she was a cheerleader for the football team, they are now turning the...

• Mr. T's Lessons on Life and Lymphoma

  There are several things that Mr. T is known for, including his career as a WWF wrestler and his role as B.A. Baracus in the hit series ‘The A-Team’. To this day, he continues to remain a fun and stylish icon of the 80s. Nevertheless, Mr. T is not only known for his appearances on television,...

• The Lymphoma Research Foundation's Light it Red for Lymphoma Night

  Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...

• Morphos Declared a "Breakthrough Therapy" for Lymphoma

  MorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...

• Little Boy Tugs at Heartstrings of Entire Community: Be the Match!

  Danny Feltwell, a young six-year-old boy, was diagnosed with T-cell lymphoblastic lymphoma when he was just two years old. After undergoing countless procedures and just four months from being considered fully cured, Danny relapsed and had to be re-hospitalized. The doctors found that a large tumor...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...